Thank you to Mick Antoniw for raising that. I know that he has had the opportunity to raise this directly with the health Minister on behalf of his constituent as well. I will say that I understand that it was the case that the recommendation by the All Wales Medicines Strategy Group to allow this drug for use in Wales was ratified by the Welsh Government on 12 December, and it has been made available in health boards. But I do understand that there is a specific delay in Cardiff and the Vale, and I understand that that is due to consultant vacancies. I can reassure Mick Antoniw that Dr Andrew Goodall has written to the chief executive of Cardiff and Vale University Health Board in December asking for an update on that latest position and what the health board is proposing to do to ensure that patients can access the drug without delay, and the health Minister will update Mick Antoniw as soon as we do have a response from the health board on that.